17 Settembre 2018 - Bando per assegnazione di una borsa di studio annuale per ricerca aperta a figura con formazione in psicologia.
Contenuti in "Ricerca"
September 24, 2016 - The EHDN 2016 Meeting was held in The Netherlands on September 16 to18, 2016: 920 participants, 312 posters, 49 Countries and many updates on research.
Cell transplantation from Pigs: the basis for potentially innovative treatments in Huntington's Disease
June 3, 2016 - “The results of this research, along with those recently obtained for other devastating neurodegenerative diseases, such as ALS, may open new important scenarios in the treatment of these severe – and up to now uncurable – diseases”.
September 3, 2015 - Evotec AG announced yesterday, September 2, that CHDI Foundation has extended and expanded its collaboration with Evotec through to August 2018. The collaboration is intended to find new tretments for Huntington's Disease.
August 22, 2015 - On 21July, the pharmaceutical company ISIS announced that the experimental Phase I Study with ISIS - HTTRx will start in August. 36 patients from three Countries (Canada, England and Germany) are planned to be recruited.
August 20, 2015 - Teva Pharmaceutical Industries Ltd announced on Aug. 12, 2015 that the New Drug Application (NDA) for SD-809 (deutetrabenazine) has been accepted by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntington Disease.
July 15, 2015 - Casa Sollievo della Sofferenza Foundation and CSS Mendel Institute launch the Research and Cure for Huntington and Rare Diseases Unit, leaded by prof Ferdinando Squitieri
June 6, 2015 - The next conference on Neurological Clinical Trials will be held in Milan the next June, 25. A focus on Huntington Disease will be presented by Prof Ferdinando Squitieri.
February 24, 2015 - Siena Biotech' failure doesn't imply there is no more hope to find a cure for Huntington Disease.